Logo image of PHG

KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PHG - US5004723038

28.07 USD
+0.22 (+0.79%)
Last: 11/26/2025, 8:04:00 PM
28.08 USD
+0.01 (+0.04%)
After Hours: 11/26/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, PHG scores 4 out of 10 in our fundamental rating. PHG was compared to 188 industry peers in the Health Care Equipment & Supplies industry. PHG has a medium profitability rating, but doesn't score so well on its financial health evaluation. PHG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

PHG had positive earnings in the past year.
PHG had a positive operating cash flow in the past year.
In multiple years PHG reported negative net income over the last 5 years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

PHG has a Return On Assets of 0.61%. This is in the better half of the industry: PHG outperforms 73.40% of its industry peers.
PHG has a Return On Equity of 1.56%. This is in the better half of the industry: PHG outperforms 74.47% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.49%, PHG is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.49%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Profit Margin of PHG (0.91%) is better than 73.40% of its industry peers.
PHG has a better Operating Margin (6.11%) than 71.28% of its industry peers.
In the last couple of years the Operating Margin of PHG has declined.
Looking at the Gross Margin, with a value of 43.85%, PHG is doing worse than 62.77% of the companies in the same industry.
PHG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

PHG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PHG has been reduced compared to 1 year ago.
The number of shares outstanding for PHG has been increased compared to 5 years ago.
Compared to 1 year ago, PHG has a worse debt to assets ratio.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 1.93 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.93, PHG is in line with its industry, outperforming 59.57% of the companies in the same industry.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PHG (19.41) is better than 70.21% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 68.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.93
ROIC/WACC0.67
WACC6.68%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.26 indicates that PHG should not have too much problems paying its short term obligations.
PHG has a worse Current ratio (1.26) than 81.91% of its industry peers.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a Quick ratio of 0.81. This is amonst the worse of the industry: PHG underperforms 84.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.15% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
The Revenue has decreased by -0.81% in the past year.
Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
PHG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.65% yearly.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.42 indicates a correct valuation of PHG.
PHG's Price/Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 86.17% of the companies in the same industry.
PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.85, which indicates a correct valuation of PHG.
85.64% of the companies in the same industry are more expensive than PHG, based on the Price/Forward Earnings ratio.
PHG is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.42
Fwd PE 15.85
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 87.77% of the companies listed in the same industry.
PHG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHG is cheaper than 73.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 53.8
EV/EBITDA 12.55
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)69.09
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.09%, PHG is a good candidate for dividend investing.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.72. PHG pays more dividend than 98.94% of the companies in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.09%

5.2 History

The dividend of PHG decreases each year by -70.49%.
PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2025 0.5 1 1.5

5.3 Sustainability

PHG pays out 0.62% of its income as dividend. This is a sustainable payout ratio.
DP0.62%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (11/26/2025, 8:04:00 PM)

After market: 28.08 +0.01 (+0.04%)

28.07

+0.22 (+0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners47.54%
Inst Owner Change-2.3%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap27.03B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target31.98 (13.93%)
Short Float %0.26%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield 4.09%
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-13 2025-05-13 (0.9673)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.49%
PT rev (3m)0.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 16.42
Fwd PE 15.85
P/S 1.31
P/FCF 53.8
P/OCF 21.24
P/B 2.25
P/tB N/A
EV/EBITDA 12.55
EPS(TTM)1.71
EY6.09%
EPS(NY)1.77
Fwd EY6.31%
FCF(TTM)0.52
FCFY1.86%
OCF(TTM)1.32
OCFY4.71%
SpS21.47
BVpS12.48
TBVpS-2.04
PEG (NY)69.09
PEG (5Y)N/A
Graham Number21.91
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.49%
ROICexc 4.97%
ROICexgc 16.33%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.93
F-Score8
WACC6.68%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


What is the valuation status for PHG stock?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.


What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 16.42 and the Price/Book (PB) ratio is 2.25.


What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 0.24% in the next year.